LOS ANGELES–(BUSINESS WIRE)– #REMAP_CAP–Global Coalition for Adaptive Research (LOS ANGELES, CA) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) — The Global Coalition for Adaptive Research (GCAR), in collaboration with UPMC (U… […]
IRVINE, Calif., June 29, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced it has signed a definitive agreement with the University of Texas Health Science Center at Houston (“UTH”) to join the clinical trial for Biomerica’s new … […]
LOS ANGELES–(BUSINESS WIRE)—- $CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) today announced the results of multiple new preclinical studies that illustrate the multifaceted potential of Niagen® (nicotinamide riboside or NR) in bolstering cell… […]
The importance of a global approach to vaccine development and production, with a focus on collaboration, was a topic of a technical update and press briefing held 26 June by the WHO.
Soumya Swaminathan
The usual practices for drug development have bee… […]
TORRANCE, Calif., June 29, 2020 (GLOBE NEWSWIRE) — Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it was issued a license from the Israeli Ministry of Health on June 17, 2020 granting market… […]
In a first for CRISPR — a field that’s seen quite a few historic moves in the past couple of years — scientists have slashed cholesterol and lipid levels in monkeys using a technique known as base editing, generating crucial proof-of-concept for both t… […]
The new lab study finds an unexpected glitch in a gene that supervises mitosis, one that has important implications for cancer treatment. […]
In 2006, a German biotech developed what they called a “superagonist” for CD28, a pocket on T cells that in theory could be used to stimulate their ability to fight cancer. They put it in 6 healthy volunteers, each of whom became critically ill within … […]
CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biomedical research… […]
CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biomedical research… […]
Copyright © 2021 Biotech Networks, LLC
